Broad-Spectrum Antimicrobials

Lakewood-Amedex Advances Nu-3 Gel Toward Phase 2a Trial

SARASOTA, Fla., July 15, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced encouraging preclinical safety results supporting dose selection for the...

By cGxPwire Editor
July 17, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Broad-Spectrum Antimicrobials

Lakewood-Amedex Advances Nu-3 Gel Toward Phase 2a Trial